|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Primary Prevention of Sudden Cardiac Death in a Nonischemic Dilated Cardiomyopathy Population: Reappraisal of the Role of Programmed Ventricular Stimulation显示文摘 | Konstantinos A. Gatzoulis Apostolos-Ilias Vouliotis Dimitris Tsiachris Maria Salourou Stefanos Archontakis Polychronis Dilaveris Theodoros Gialernios Petros Arsenos Georgios Karystinos Skevos Sideris Ioannis Kallikazaros Christodoulos Stefanadis | 2013 | Circulation: Arrhythmia and Electrophysiology2013，，3： | 2 |
| 2 | Functional results of speech and swallowing after oral microvascular free flap reconstruction显示文摘 | Archontaki M Athanasiou A Stavrianos SD | 2010 | Eur Arch Otorhinolaryngol2010，267，： | 1 |
| 3 | Determination of intralumenal individual bile acids by HPLC with charged aerosol detection显示文摘 | Vertzoni M Archontaki H Reppas C | 2008 | J Lipid Res2008，49，12： | 1 |
| 4 | Semi-antomated kinetic determination of phenolic compounds using a fluoride-selective electrode and based on their micellar-catalysed with 1-fluoro-2, 4-dinitrobenzene显示文摘 | Archontaki HA Koupparis MA Efstathiou CE | 1989 | Analyst1989，114，： | 1 |
| 5 | C18 columns for the si-multaneous determination of oxytetracycline and its relatedsubstances by reversed-phase high performance liquid chro-matography and UV detection显示文摘 | Smyrniotakis C G Archontaki H A | 2007 | Journal of Pharmaceuticaland Biomedical Analysis2007，43，2： | 1 |
| 6 | Study on the inclusion complexes of bromazepam with β-and β-hydroxypropyl-cyclodextrins 显示文摘 | ARCHONTAKI H A VERTZONI M V ATHANASSIOUMALAKI M H | 2002 | J Pharm Biomed Anal2002，28，34： | 1 |
| 7 | Development and optimization of a reversed phase high - performance liquid chromatographic method for the determination of paracetamol and its major metabolites in rabbit plasma and urine after a toxic dose 显示文摘 | VERTZONI M V ARCHONTAKI H A GAL ANOPOULOU P | 2003 | J Pharm Biomed Anal2003，32，3： | 1 |
| 8 | Der?matofibrosarcoma protuberans , a case series of 16 patients treated in a single institution with literature review 显示文摘 | Archontaki M Korkolis DP Arnogiannaki N | 2010 | Anticancer Res2010，30，9： | 1 |
| 9 | Freemicrovasculartissuetransfer for the reconstruction of midfacialdefects in oncologicalpatients显示文摘 | Archontaki M Stavrianos SD Rapidis AD | 2010 | Med Oral Patol Oral Cir Bucal2010，15，5： | 1 |
| 10 | Kinetic study on the degradation of prazepam in acidic aqueous solution by highperformance liquid chromatography and fourth-order derivative ultraviolet spectrophotometry显示文摘 | Archontaki H A Panderi I E Gikas E E | 1998 | Journal of Pharmaceutical and Biomedical Analysis1998，17，： | 1 |
| 11 | Kinetic Study on the Acidic Hydrolysis of Lorazepam by a Zero-Crossing First-Order Derivative UV-Spectrophotometric Technique显示文摘 | Archontaki H A Atmian K Panderi I E Gikas E E | 1999 | Talanta1999，48，3： | 1 |
| 12 | Implantable cardioverter defibrillator therapy activation for high risk patients with relatively well preserved left ventricular ejection fraction. Does it really work?显示文摘 | Konstantinos A. Gatzoulis Dimitris Tsiachris Polichronis Dilaveris Stefanos Archontakis Petros Arsenos Apostolis Vouliotis Skevos Sideris George Trantalis Efstathios Kartsagoulis Ioannis Kallikazaros Christodoulos Stefanadis | 2012 | International Journal of Cardiology2012，，： | 1 |
| 13 | Optimized deterruination of lycopene in canine plasma using reversed-phase high-perfor- mance liquid chromatography显示文摘 | VERTZONI M V REPPAS C ARCHONTAKI H A | 2005 | J Chromatogr B2005，819，1： | 1 |
| 14 | Arrhythmic risk stratification in ischemic,non-ischemic and hypertrophic cardiomyopathy:A two-step multifactorial,electrophysiology study inclusive approach显示文摘Annual arrhythmic sudden cardiac death ranges from 0.6%to 4%in ischemic cardiomyopathy(ICM),1%to 2%in non-ischemic cardiomyopathy(NICM),and 1%in hypertrophic cardiomyopathy(HCM).Towards a more effective arrhythmic risk stratification(ARS)we hereby present a two-step ARS with the usage of seven non-invasive risk factors:Late potentials presence(≥2/3 positive criteria),premature ventricular contractions(≥30/h),non-sustained ventricular tachycardia(≥1episode/24 h),abnormal heart rate turbulence(onset≥0%and slope≤2.5 ms)and reduced deceleration capacity(≤4.5 ms),abnormal T wave alternans(≥65μV),decreased heart rate variability(SDNN<70ms),and prolonged QT_(c)interval(>440 ms in males and>450 ms in females)which reflect the arrhythmogenic mechanisms for the selection of the intermediate arrhythmic risk patients in the first step.In the second step,these intermediate-risk patients undergo a programmed ventricular stimulation(PVS)for the detection of inducible,truly high-risk ICM and NICM patients,who will benefit from an implantable cardioverter defibrillator.For HCM patients,we also suggest the incorporation of the PVS either for the low HCM Risk-score patients or for the patients with one traditional risk factor in order to improve the inadequate sensitivity of the former and the low specificity of the latter. | Petros Arsenos Konstantinos A Gatzoulis Dimitrios Tsiachris Polychronis Dilaveris Skevos Sideris Ilias Sotiropoulos Stefanos Archontakis Christos-Konstantinos Antoniou Athanasios Kordalis Ioannis Skiadas Konstantinos Toutouzas Charalambos Vlachopoulos Dimitrios Tousoulis Konstantinos Tsioufis | 2022 | World Journal of Cardiology2022，14，3： | 1 |
| 15 | Prognostic value of programmed ventricular stimulation for sudden death in selected high risk patients with structural heart disease and preserved systolic function显示文摘 | Konstantinos A. Gatzoulis Dimitris Tsiachris Petros Arsenos Stefanos Archontakis Polychronis Dilaveris Apostolis Vouliotis Skevos Sideris Ioannis Skiadas Ioannis Kallikazaros Christodoulos Stefanadis | 2014 | International Journal of Cardiology2014，，： | 1 |
| 16 | Functionalresults of speech and swallowing after oral microvascular free flapreconstruction 显示文摘 | Archontaki M Athanasiou A Stavrianos SD | 2010 | Eur Arch Otorhinolaryngol2010，267，11： | 1 |
| 17 | Study on the inclusion complexes of bromazepam with β-cyclodextrins and β-hydroxypropyl-cyclodextrins 显示文摘 | ARCHONTAKI H A VERTZONI M V ATHANASSIOU M H | 2002 | Journal of Pharmaceutical and Biomedical Analysis2002，28，3： | 1 |
| 18 | Study on the inclusion complexes of bromazepam with β-and β-hydroxypropylcyclodextrins 显示文摘 | Archontaki HA Vertzoni MV Athanassiou-Malaki MH | 2002 | J Pharm Biomed2002，28，34： | 1 |
| 19 | Optimizeddetermination of lycopene in canine plasma using reversed-phase high-performance liquid chromatography显示文摘 | VERTZONI M V REPPAS C ARCHONTAKI H A | 2005 | J Chromatogr B2005，819，1： | 1 |
| 20 | Development and optimization of a reversed-phase high-performance liquid chromatographic method for the determination of paracetamol and its major metabolites in rabbit plasma and urine after a toxic dose显示文摘 | Vertzoni M V Archontaki H A Galanopoulou P | 2003 | J Pharm Biomed Anal2003，32，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员